Virginijos Černiūtės odos ligų kabinetas, UAB - financials and debts
Company age: 26 y. 1 mo.
Virginijos Černiūtės odos ligų kabinetas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 68,653 | 74,259 | 81,037 | 96,003 | 110,453 | 130,206 | 147,922 | 173,065 |
| Profit before tax | 50,218 | 52,911 | 60,065 | 72,912 | 88,250 | 104,916 | 122,474 | 154,550 |
| Net profit | 50,214 | 52,908 | 60,062 | 72,912 | 88,250 | 104,916 | 122,474 | 154,550 |
| Equity | 53,281 | 56,094 | 63,258 | 76,167 | 91,967 | 108,633 | 126,191 | 158,740 |
| Liabilities | 202 | 136 | 206 | 397 | 704 | 812 | 732 | 826 |
| Non-current assets | 2,232 | 1,288 | 1,355 | 834 | 834 | 834 | 834 | 701 |
| Current assets | 51,251 | 54,942 | 62,109 | 75,730 | 91,664 | 108,447 | 126,050 | 158,745 |
| Total assets | 53,483 | 56,230 | 63,464 | 76,564 | 92,498 | 109,281 | 126,884 | 159,446 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 14,878 | 17,407 | 18,887 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.2% | +8.2% | +9.1% | +18.5% | +15.1% | +17.9% | +13.6% | +17.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 93.9% | 94.1% | 94.6% | 95.2% | 95.4% | 96.0% | 96.5% | 96.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 94.2% | 94.3% | 94.9% | 95.7% | 96.0% | 96.6% | 97.1% | 97.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 73.1% | 71.2% | 74.1% | 75.9% | 79.9% | 80.6% | 82.8% | 89.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 73.1% | 71.3% | 74.1% | 75.9% | 79.9% | 80.6% | 82.8% | 89.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 25,745 | 24,753 | 27,012 | 32,001 | 36,818 | 43,402 | 49,307 | 83,073 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Virginijos Černiūtės odos ligų kabinetas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-01-16 | 2025-02-11 | 0.16 |
| 2024-12-22 | 2024-12-26 | 0.18 |
| 2024-12-17 | 2024-12-20 | 0.18 |
| 2024-11-18 | 2024-12-11 | 0.20 |
| 2024-10-16 | 2024-11-11 | 0.22 |
| 2024-09-17 | 2024-10-08 | 0.22 |
| 2024-08-19 | 2024-09-11 | 0.12 |
| 2024-07-16 | 2024-08-12 | 0.12 |
| 2023-12-18 | 2023-12-26 | 5.44 |
| 2023-11-16 | 2023-12-11 | 5.44 |
| 2023-10-17 | 2023-11-09 | 5.44 |
| 2022-02-17 | 2022-03-13 | 0.13 |
| 2022-01-28 | 2022-02-13 | 0.14 |
| 2022-01-18 | 2022-01-20 | 65.64 |
| 2021-12-16 | 2021-12-21 | 66.15 |
| 2021-11-08 | 2021-11-14 | 0.23 |
Virginijos Černiūtės odos ligų kabinetas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Virginijos Černiūtės odos ligų kabinetas is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-18 | 2026-09-02 | 0.58 |
| 2026-02-21 | 2026-02-21 | 0.58 |
| 2026-02-03 | 2026-02-16 | 0.58 |
| 2026-01-31 | 2026-02-02 | 0.39 |
| 2026-01-14 | 2026-01-19 | 30.13 |
| 2025-05-17 | 2025-05-19 | 18300.0 |
| 2025-04-03 | 2025-04-23 | 18298.11 |
| 2025-01-14 | 2025-02-10 | 0.11 |
| 2024-08-14 | 2025-01-13 | 0.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Virginijos Cerniutes odos ligu kabinetas, UAB (code 151429967) is a private limited liability company engaged in medical specialists activities. In 2025, the company generated revenue of €173.1K and net profit of €154.6K, resulting in a profit margin of 89.3%. Performance strengthened over the last three years: revenue increased from €130.2K in 2023 to €147.9K in 2024 and €173.1K in 2025, while net profit rose from €104.9K to €122.5K and then to €154.6K. The balance sheet remained very conservative, with total assets of €159.4K, equity of €158.7K and liabilities of only €826 in 2025. The equity ratio was 99.6% and debt-to-equity stood at 0.01, indicating minimal leverage. Return on equity was 97.4% and return on assets was 96.9%, supported by asset turnover of 1.09x. Revenue per employee was €86.5K and profit per employee was €77.3K, pointing to strong operating productivity in 2025.